Medifast (MED) Raw Materials (2011 - 2021)

Medifast has reported Raw Materials for 9 years, with the latest figure at $13.8 million in Q3 2021.

• For the quarter ending Q3 2021, Raw Materials rose 1.01% year-over-year to $13.8 million; the trailing twelve-month figure through Sep 2021 stood at $13.8 million (up 1.01% YoY), and the FY2020 full-year result was $13.4 million, up 23.42% from the prior year.
• Raw Materials for Q3 2021 stood at $13.8 million, up from $9.5 million in the prior quarter.
• The five-year high for Raw Materials was $13.8 million in Q3 2021, with the low at $4.3 million in Q3 2017.
• Historically, Raw Materials has averaged $9.6 million across 5 years, with a median of $10.5 million in 2019.
• Annual changes were most pronounced in 2017 — Raw Materials fell 27.71% — and 2018, when it jumped 212.16%.
• Medifast's Raw Materials stood at $4.3 million in 2017, then soared by 156.58% to $11.2 million in 2018, then decreased by 2.47% to $10.9 million in 2019, then rose by 23.42% to $13.4 million in 2020, then grew by 3.07% to $13.8 million in 2021.
• The last three Raw Materials figures came in at $13.8 million (Q3 2021), $9.5 million (Q2 2021), and $11.2 million (Q1 2021), per Business Quant data.